knowledge -WSS

knowledge

author：entertainment 2025-09-29 17:02:01 - browse：3

Adam's take main illustration — Molly Ferguson/STAT

Some day-after thoughts on Bristol Myers Squibb acquiring Mirati Therapeutics:

A take-under deal feels meh for biotech sector sentiment.Bristol is paying $58 per share in cash for Mirati, which closed Friday at $60. Granted, Mirati was trading in the $30 range in September, so from there, the roughly 50% premium isn’t terrible. But as Mizuho strategist Jared Holz pointed out, investors would liked to have seen Mirati go for $75-$100 per share.

With the closely watched XBI biotech index down 13% for the year, every M&A deal helps improve sentiment, but this one — maybe just a little. Bristol is paying $4.8 billion in cash to acquire Mirati, or $3.7 billion after accounting for Mirati’s cash. It’s a small bolt-on acquisition for Bristol, which isn’t overpaying.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

WSS

Climate activists disrupt London Pride march to protest corporate sponsorship

Parkinson’s finding may lead to tests and, someday, treatments

Calls for Trump's election interference trial to be televised part of long debate

California Joshua trees severely burned in massive wildfire

Teen charged with murder as hate crime in killing of NYC dancer O'Shae Sibley: Sources

Biotech venture capitalists face new demands from investors

explore

knowledge

explore

Affirmative action in medical school literally saved lives

Slain Parkland victim's father speaks out following reenactment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Supreme Court strikes down use of affirmative action

Parkinson’s finding may lead to tests and, someday, treatments

Duchenne breakthrough therapy leaves behind pioneering families

My yearlong odyssey to get my son’s ADHD medication covered

Virginia high school admissions case could be legal follow

New brain studies show LSD's effects on the brain in full color

entertainment

Think you might have Covid

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

AI generated plenty of interest at JPM but not a lot of trust

New brain studies show LSD's effects on the brain in full color

AI generated plenty of interest at JPM but not a lot of trust

Pediatricians' group reaffirms support for gender

focus

hotspot

hotspot

focus